Canada· CA-DIN-02521407
MILRINONE LACTATE INJECTION USP
A milrinone product containing milrinone (milrinone lactate), registered in Canada by MARCAN PHARMACEUTICALS INC. The same ATC class is registered in 16 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Milrinone is registered in 16 of 19 countries.
Countries holding a registration under ATC C01CE02 (milrinone), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Milrinone · ATC C01CE02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- MILRINONE (MILRINONE LACTATE)
- Manufacturer
- MARCAN PHARMACEUTICALS INC
- Country
- Canada (CA)
- ATC code
- C01CE02
- ATC class
- Milrinone
- Defined daily dose
- 50 mg, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for milrinone.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Milrinone · interactions on record
5 records
- 5 moderate
Most severe, free to view
- ProcarbazineL01XB01moderate
- AnagrelideL01XX35moderate
- OzanimodL04AA38moderate
- OzanimodL04AE02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Milrinone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMilrinone LactateMullan Pharmaceutical Inc.
- United KingdomMilrinone 10mg/10ml concentrate for solution for infusion ampoulesStragen UK Ltd
- GermanyCorotropSanofi-Aventis Deutschland Gmbh
- FranceCOROTROPE 10 mg/10 ml, solution injectable IVSANOFI WINTHROP INDUSTRIE
- Japanミルリノン富士製薬工業
- BelgiumCorotrope 1 mg/mlSanofi Belgium
- FinlandMilnifarmOrifarm Oy
- NetherlandsMilrinon Carinopharm 1 mg/ml oplossing voor injectie/infusieCarinopharm GmbH
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Asicor, Milrinon Carino
- Belgium · Corotrope
- Bulgaria · Milrinon Makpharm
- Czechia · Asicord, Corotrop
- Germany · Corotrop, Milrinon Carinopharm
- Denmark · Milnocor, Milrinon Stragen
- Spain · Corotrope, Milrinone
- Finland · Milnocor, Milrinon Stragen
- France · Corotrope, Milrinone Carinopharm
- United Kingdom (Northern Ireland) · Milrinone Carinopharm, Milrinone Macure Pharma Uk
- Greece · Corotrope
- Croatia · Milrinon Makpharm
- Hungary · Corotrope, Unacor
- Ireland · Milrinone Pinewood Laboratories
- Luxembourg · Corotrope
- Malta · Milrinone Tillomed
- Netherlands · Milrinon Carinopharm, Milrinon Devrimed
- Norway · Milnocor, Milrinon Stragen
- Poland · Asicor, Corotrope
- Portugal · Corotrope
- Romania · Milrinone Zentiva, Unacor
- Sweden · Corotrop, Milrinon Carinopharm
- Slovenia · Milrinon Makpharm
- Slovakia · Asicord, Corotrope Inj
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1b24c748-1d75-4e20-8e7a-48de5cc1eebd GET /v1/drugs/1b24c748-1d75-4e20-8e7a-48de5cc1eebd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02521407",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "C01CE02",
"schedule": [
"Prescription"
],
"drug_code": "101060",
"strengths": [
"1 MG"
],
"ahfs_class": null,
"substances": [
"MILRINONE (MILRINONE LACTATE)"
],
"product_categorization": null
}See everything about milrinone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.